BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/26/2025 10:27:31 AM | Browse: 2 | Download: 1
 |
Received |
|
2025-09-15 03:05 |
|
Peer-Review Started |
|
2025-09-15 03:05 |
|
First Decision by Editorial Office Director |
|
2025-09-28 10:41 |
|
Return for Revision |
|
2025-09-28 10:41 |
|
Revised |
|
2025-10-01 15:46 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-11-24 02:45 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-11-24 05:55 |
|
Articles in Press |
|
2025-11-24 05:55 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-12-18 02:20 |
|
Publish the Manuscript Online |
|
2025-12-26 10:27 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Drug-induced liver injury in inflammatory bowel disease: Challenges in diagnosis and monitoring
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Arshdeep Singh, Arshia Bhardwaj, Harmeet Kaur, Ashutosh Bawa, Vandana Midha and Ajit Sood |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Arshdeep Singh, Associate Professor, Department of Gastroenterology, Dayanand Medical College and Hospital, Tagore Nagar Civil Lines, Ludhiana 141001, Punjab, India. drarshdeepsingh@gmail.com |
| Key Words |
Drug-induced liver injury; Hepatotoxicity; Immunosuppressive agents; Inflammatory bowel diseases; Monitoring |
| Core Tip |
Drug-induced liver injury (DILI) in inflammatory bowel disease (IBD) is often underrecognized due to overlapping hepatobiliary disorders and nonspecific presentations. Distinguishing true DILI from IBD-related liver disease requires systematic evaluation, multidisciplinary input, and structured monitoring strategies. This review synthesizes current evidence on the epidemiology, mechanisms, and diagnostic challenges of DILI in IBD, highlighting practical approaches to optimize early detection and safe therapeutic decision-making. |
| Publish Date |
2025-12-26 10:27 |
| Citation |
Singh A, Bhardwaj A, Kaur H, Bawa A, Midha V, Sood A. Drug-induced liver injury in inflammatory bowel disease: Challenges in diagnosis and monitoring. World J Hepatol 2025; 17(12): 114084 |
| URL |
https://www.wjgnet.com/1948-5182/full/v17/i12/114084.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v17.i12.114084 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
